| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |